TrialCirculation. Arrhythmia and electrophysiology2017

Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Thomas A Dewland et al.PubMed ↗Full text ↗Publisher ↗

Published long after NCT00000542 ended. The trial’s primary report, PMID 12479764, speaks for it on the map; the numbers here are shown and do not vote.

What the trial testedas reported · 837 people · 2017

Range includes no effect

No clear effect on blood pressure

+4%−6% to +15%

Bigger than 1 in 10 on the map

As reported

HR 1.04, 95% CI 0.94–1.15

One number in the abstract

the abstract, start to end

… to either lisinopril (hazard ratio, 1.04; 95% confidence interval, …

← favours treatmentfavours comparator →

could be chance

Blood pressure

HR 1.040.94–1.15

AntihypertensivesBlood pressure

1 / 3

6 papers cite it

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this papercites it

The trial

NCT00000542phase 31993a later paper about it